8-K current report · filed Aug 5, 2026

Charles River Laboratories (CRL) 8-K Current Report: August 5, 2026

Item 2.02Item EX-99.1CRL overview

Short answer

Charles River Laboratories (CRL) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 FY2026 results released August 5, 2026, covering the quarter ended June 27, 2026.

Charles River Laboratories 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q2 FY2026 results released August 5, 2026, covering the quarter ended June 27, 2026
  • Financial performance details contained in the attached press-release exhibit
  • Forward-looking statements subject to identified risks in Charles River’s SEC filings

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $1.00B, down 2.7% YoY, while organic growth reached 0.1%, the strongest since Q3 2023
  • Non-GAAP EPS $3.02, down 3.2% YoY, with margin pressured by higher DSA study costs and corporate expenses
  • GAAP loss $(0.03) per share, reflecting a $63.7M divestiture loss, despite GAAP operating margin improving to 11.9%
  • 2026 organic revenue guidance raised to 0.0%-1.0% and non-GAAP EPS to $11.15-$11.45
  • $100M repurchase in Q2, with $700M remaining under the $1.0B authorization, supporting per-share results but increasing capital commitments

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Charles River Laboratories 8-K filings

Get the next CRL 8-K as it lands

Follow CRL for push alerts, or ask the research agent what this filing means.